Clinical Trials Directory

Trials / Completed

CompletedNCT02589288

Adductor Canal Block: Continuous Infusion Versus Automatic Intermittent Bolus

Adductor Canal Block: Continuous Infusion Versus Automatic Intermittent Bolus For Postoperative Analgesia After Day-Case Anterior Cruciate Ligament Reconstruction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
ASST Gaetano Pini-CTO · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this prospective, randomized , blinded study is to compare two different infusion techniques (continuous VS intermittent automatic bolus) to assess the effects of postoperative analgesia after Day-Case anterior cruciate ligament (ACL) reconstruction.

Conditions

Interventions

TypeNameDescription
PROCEDUREContinuous Infusion of ropivacaine 0.2%Postoperative continuous infusion of Ropivacaine 0,2% at 6 ml/h and 4 ml PCA bolus, lockout 20 minutes via electronic infusion pump (Micrel device, Greece).
PROCEDUREAutomatic Intermittent Bolus of ropivacaine 0.2%Postoperative Automatic Intermittent Bolus of 6 ml Ropivacaine 0,2% every hour and 4 ml PCA bolus, lockout 20 minutes via electronic infusion pump (Micrel device, Greece).

Timeline

Start date
2015-11-01
Primary completion
2016-12-01
Completion
2017-03-01
First posted
2015-10-28
Last updated
2017-08-14

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02589288. Inclusion in this directory is not an endorsement.